NCT00232440

Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma

A Study to Examine the Reproducibility of an Immobilization Device (BodyFIX ) to Deliver High Precision Radiation Therapy for Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 20 (planned)
• Sponsor: University Health Network, Toronto · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Radiation therapy has a well-established role in the treatment of Hodgkin's Disease and non-Hodgkin's Lymphoma. With technological developments, 3-D Dimensional (3D) planning has evolved as a highly precise treatment planning option. High-precision radiation therapy has the potential for more accurate dose delivery to the tumour volume and can result in a greater sparing of normal tissue. An important component of safe radiotherapy delivery is the feasibility and reproducibility of current and new immobilization devices for highly conformal treatment. The purpose of this study is to determine the reproducibility of an immobilization device known as BodyFIX(TM) using conventional treatment techniques.

Conditions

• Hodgkin's Disease
• Lymphoma, Non-Hodgkin

Interventions

Type	Name	Description
DEVICE	BodyFIX

Timeline

• Start date: 2003-01-01
• Primary completion: 2009-06-01
• Completion: 2009-06-01
• First posted: 2005-10-04
• Last updated: 2010-08-11

Locations

1 site across 1 country: Canada